Cargando…
IGF-I and IGFBP-3 and the risk of lung cancer: A meta-analysis based on nested case-control studies
BACKGROUND: Lung cancer is the leading cause of death from cancer worldwide. Conventional studies mainly think that insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) may promote and inhibit tumor growth, respectively. However, there are many different results about their funct...
Autores principales: | Chen, Bo, Liu, Shan, Xu, Wei, Wang, Xueli, Zhao, Weihong, Wu, Jianqing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706806/ https://www.ncbi.nlm.nih.gov/pubmed/19549343 http://dx.doi.org/10.1186/1756-9966-28-89 |
Ejemplares similares
-
Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study
por: Rosendahl, Ann H., et al.
Publicado: (2021) -
Association between Circulating Levels of IGF-1 and IGFBP-3 and Lung Cancer Risk: A Meta-Analysis
por: Cao, Hongxin, et al.
Publicado: (2012) -
Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs
por: Song, Doo-Won, et al.
Publicado: (2021) -
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies
por: Watts, Eleanor L., et al.
Publicado: (2019) -
IGF-1 and IGFBP-3 in Inflammatory Cachexia
por: Martín, Ana Isabel, et al.
Publicado: (2021)